Bavarian Nordic — Marts 2022
-
nu følger der jo kun 85mill DKK med i forudbetaling, det er ikke nok til at ændre på ret meget, resten er afhæning af milestones.
-
lidelse er der kø ved udgangen da der på trods af denne positive aftale ikke er udsigt til andet der kan give øget indtægter i år. når først der begynder at komme penge i kassen skal kursen nok komme nordpå
-
Bavarian-direktør sigter efter flere aftaler - håber på globale https://proinvestor.com/investornyt/798077/bavarian-direktor-sigter-efter-flere-aftaler-haber-pa-globale
-
Bavarian Nordic's deal with Nuance Pharma to develop and sell the RSV vaccine in China and other Asian markets is a positive surprise, analysts at Carnegie said.
• RSV deals were not expected until next year, according to Carnegie, and this agreement could add more than 5% to Bavarian's valuation, the analysts said -
A global partnership deal for the RSV vaccine is still expected during the second half of next year, and this agreement in China should not negatively impact that, the analysts said
-
Bavarian Nordic: Lille stigning viser store udfordringer https://www.proinvestor.com/boards/102254
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind